Correlation Between LMF Acquisition and Dermata Therapeutics

Can any of the company-specific risk be diversified away by investing in both LMF Acquisition and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LMF Acquisition and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between LMF Acquisition Opportunities and Dermata Therapeutics, you can compare the effects of market volatilities on LMF Acquisition and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LMF Acquisition with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of LMF Acquisition and Dermata Therapeutics.

Diversification Opportunities for LMF Acquisition and Dermata Therapeutics

0.25

Correlation Coefficient

LMF Acquisition  Dermata Therapeutics

Modest diversification

The 3 months correlation between LMF and Dermata is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding LMF Acquisition Opportunities and Dermata Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and LMF Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LMF Acquisition Opportunities are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of LMF Acquisition i.e., LMF Acquisition and Dermata Therapeutics go up and down completely randomly.

Pair Corralation between LMF Acquisition and Dermata Therapeutics

Considering the 90-day investment horizon LMF Acquisition Opportunities is expected to generate 1.2 times more return on investment than Dermata Therapeutics. However, LMF Acquisition is 1.2 times more volatile than Dermata Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Dermata Therapeutics is currently generating about 0.03 per unit of risk. If you would invest  204.00  in LMF Acquisition Opportunities on December 27, 2024 and sell it today you would earn a total of  39.00  from holding LMF Acquisition Opportunities or generate 19.12% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

LMF Acquisition Opportunities  vs.  Dermata Therapeutics

LMF Acquisition Oppo

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in LMF Acquisition Opportunities are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent fundamental indicators, LMF Acquisition unveiled solid returns over the last few months and may actually be approaching a breakup point.

Dermata Therapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Dermata Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, Dermata Therapeutics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with LMF Acquisition and Dermata Therapeutics

The main advantage of trading using opposite LMF Acquisition and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LMF Acquisition position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.

The idea behind LMF Acquisition Opportunities and Dermata Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.